Toru Seo
Fondatore presso HISHOH Biopharma Co., Ltd.
Profilo
Toru Seo is the founder of HISHOH Biopharma Co., Ltd.
where he holds the title of Advisor since 2021.
He is currently working as a Director at Cellusion Inc. Dr. Seo obtained a doctorate degree from Wake Forest University.
Posizioni attive di Toru Seo
| Società | Posizione | Inizio |
|---|---|---|
Cellusion Inc.
 Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Direttore/Membro del Consiglio | - |
HISHOH Biopharma Co., Ltd.
 HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Fondatore | 12/04/2021 |
Formazione di Toru Seo
| Wake Forest University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Commercial Services |
HISHOH Biopharma Co., Ltd.
HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Toru Seo
